0.1978 - 0.2199
0.18 - 0.96
Join Discuss about WORX with like-minded investors
Upside: -CNST +67% (to be acquired by Morphosys for $34.00/shr in cash; deal valued at $1.7B) -MITO +42% (receives Orphan Drug Designation from the European Medicines Agency for elamipretide for the treatment of Barth syndrome) -SLCT +21% (First Bancorp to acquire Select Bancorp, Inc. for $18.10/shr in $314M all-stock transaction) -AMC +20% (successfully sold 8.5M shares of its Class A common stock to Mudrick Capital Management, LP; launches AMC Investor Connect) -MDLA +11% (earnings, guidance) -KIN +9.8% (announces positive results from pivotal efficacy study of parvovirus monoclonal antibody for the prevention of deaths in dogs infected by parvovirus) -WORX +9.6% (Interim COO Tim Hannibal to become permanent CEO) -RLX +7.4% (earnings, guidance) -SKLZ +6.7% (acquires technology-driven marketing platform Aarki for $150M cash-stock deal) -SCYX +4.3% (announces FDA Approval of BREXAFEMME® (ibrexafungerp tablets) as the First and Only Oral Non-Azole Treatment for Vaginal Yeast Infections) -FUSN +3.8% (enters into agreement with McMaster University to build radiopharmaceutical manufacturing facility) -SFT +3.3% (executives announce purchase of shares) -AMBA +3.1% (earnings, guidance) -EVOK +2.2% (issued new US patent covering methods of use for Gimoti (metoclopramide) nasal spray) -APPS +1.9% (earnings, guidance) -CANF +1.9% (to Initiate Phase IIb NASH Study with its Drug Candidate Namodenoson) -ETSY +1.3% (acquires global fashion resale marketplace Depop for $1.63B consisting primarily of cash) -AAP +1.2% (earnings, guidance) -KODK +1.2% (issues statement responding to New York Attorney General regarding insider trading evidence) -ZM +1.2% (earnings, guidance) Downside: -IRTC -15% (CEO Michael Coyle steps down due to personal matters; affirms select Q2 guidance) -ENG -14% (registers ~7.14M shares at $2.80/shr) -LIZI -6.8% (earnings) -PROG -4.2% (launches strategic transformation into biotech company) -ADCT -4.1% (files to sell up to 5.6M shares for holders) -OMIC -3.1% (underwriters fully exercise 1.5M share overallotment option) -HPE -1.2% (earnings, guidance
130 Replies 13 👍 13 🔥
why is WORX running?
54 Replies 12 👍 15 🔥
@maletone did u cover all or WORX?
91 Replies 15 👍 13 🔥
WORX much easier to deal with on 1 min chart, covering all positions
87 Replies 15 👍 13 🔥
WORX shares just became available short at etrade so adding here
118 Replies 8 👍 15 🔥
Next Dividend Date
scworx corp. provides software solutions for the management of health care providers' foundational business applications in the united states. the company provides services related to repair, normalization, and interoperability of information, as well as big data analytics model that provides web portal for display, and reporting and analysis of the information contained within the data warehouse. it also offers various software solutions and services, such as virtualized item master file repair, expansion, and automation; electronic medical record management, a module that integrates the advanced data attributes created in the item master to the electronic medical records; charge description master management(cdm), a module, which assists healthcare providers by integrating the cdm data into the workflow of the hospitals purchasing systems; contract management, a module that assists healthcare providers to establish a contract management system and to provide care to patients; request
HQ: 590 Madison Ave New York, 10022-2524 New York